The combination of PD-1 blockade with interferon-α has a synergistic effect on hepatocellular carcinoma
2022 · Cellular and Molecular Immunology · 125 citations
https://doi.org/10.1038/s41423-022-00848-3
D
Da Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
4.5K
Citations
32
h-index
55
i10-index
Da Xu is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Colorectal Cancer Treatments and Studies & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 32, co-authored 98 publications.
ORCID: 0000-0001-5084-2802Papers by this author
worksDisruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma
2024 · Cell Reports Medicine · 54 citations
https://doi.org/10.1016/j.xcrm.2024.101415
Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma
2023 · Cell Reports Medicine · 53 citations
https://doi.org/10.1016/j.xcrm.2023.101264
TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination
2021 · Cancer Cell International · 37 citations
https://doi.org/10.1186/s12935-021-01831-0
Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study
2022 · Cell Death and Disease · 18 citations
https://doi.org/10.1038/s41419-022-04501-9
Study of cellular heterogeneity and differential dynamics of autophagy in human embryonic kidney development by single-cell RNA sequencing
2021 · Cancer Cell International · 8 citations
https://doi.org/10.1186/s12935-021-02154-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat